Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
AssigneeNew York University School of Medicine
InventorChuanju LIU
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew York University School of Medicine
InventorChuanju LIU
Estimating the term…
The present invention provides modulators of TNF, particularly peptides and their derivatives, particularly GEP peptides, which antagonize TNF and TNF-mediated responses, activity or signaling. The invention provides methods of antagonizing TNF and the modulation of TNF-mediated diseases or responses, including inflammatory diseases and conditions. Compositions of GEP peptides, including in combination with other inflammatory mediators, are provided. Methods of treatment, alleviation, or prevention of TNF-mediated diseases and inflammatory conditions, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, inflammatory bowel diseases, Chrohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, are provided.
1-21. (canceled)
An isolated peptide comprising
An isolated peptide comprising:
Dependencies are inferred from the claim text.